2025 PRIMO | Immunotherapy and Optimal Chemotherapy for Early Stage TNBC: When and in Whom?

2025 PRIMO | Immunotherapy and Optimal Chemotherapy for Early Stage TNBC: When and in Whom?

0% Complete

Course Content

Credits

  • AMA PRA Category 1 Creditâ„¢Non-CME

Course Details

Duration
0.00 hour
Released
May 14, 2025
Last Review
May 14, 2025
Expires
May 14, 2028

Faculty & Disclosure

Faculty

Hope Rugo, MD, FASCO

Disclosure

Hope Rugo, MD, FASCO discloses no such relationships exist

Accreditation

NA